Dwarfism and early death in mice lacking C-type natriuretic peptide

被引:353
|
作者
Chusho, H
Tamura, N
Ogawa, Y [1 ]
Yasoda, A
Suda, M
Miyazawa, T
Nakamura, K
Nakao, K
Kurihara, T
Komatsu, Y
Itoh, H
Tanaka, K
Saito, Y
Katsuki, M
Nakao, K
机构
[1] Kyoto Univ, Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan
[2] Suntory Inst Biomed Res, Shimamoto, Osaka 6180024, Japan
[3] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 1080071, Japan
关键词
D O I
10.1073/pnas.071389098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Longitudinal bone growth is determined by endochondral ossification that occurs as chondrocytes in the cartilaginous growth plate undergo proliferation, hypertrophy, cell death, and osteoblastic replacement. The natriuretic peptide family consists of three structurally related endogenous ligands, atrial, brain, and C-type natriuretic peptides (ANP, BNP, and CNP), and is thought to be involved in a variety of homeostatic processes. To investigate the physiological significance of CNP in vivo, we generated mice with targeted disruption of CNP (Nppc(-/-) mice). The Nppc(-/-) mice show severe dwarfism as a result of impaired endochondral ossification. They are all viable perinatally, but less than half can survive during postnatal development. The skeletal phenotypes are histologically similar to those seen in patients with achondroplasia, the most common genetic form of human dwarfism. Targeted expression of CNP in the growth plate chondrocytes can rescue the skeletal defect of Nppc(-/-) mice and allow their prolonged survival. This study demonstrates that CNP acts locally as a positive regulator of endochondral ossification in vivo and suggests its pathophysiological and therapeutic implication in some forms of skeletal dysplasia.
引用
收藏
页码:4016 / 4021
页数:6
相关论文
共 50 条
  • [31] Mechanism of relaxations to C-type natriuretic peptide in veins
    Banks, M
    Wei, CM
    Kim, CH
    Burnett, JC
    Miller, VM
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 271 (05): : H1907 - H1911
  • [32] Detection of C-type natriuretic peptide in normal pregnancy
    Stepan, H
    Walther, T
    Walther, D
    Faber, R
    JOURNAL OF PERINATAL MEDICINE, 1998, 26 (01) : 56 - 58
  • [33] C-type natriuretic peptide: An important neuroendocrine regulator?
    Fowkes, RC
    McArdle, CA
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08): : 333 - 338
  • [34] Coexistence of C-type natriuretic peptide and atrial natriuretic peptide systems in the bovine cornea
    Kim, SZ
    Kim, HS
    Lee, KS
    Lee, SJ
    Seul, KH
    Koh, GY
    Cho, KW
    Kim, SH
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (09) : 2671 - 2677
  • [35] C-type natriuretic peptide system in rabbit colon
    Kim, JH
    Jeon, GH
    Kim, SZ
    Cho, KW
    Kim, SH
    PEPTIDES, 2001, 22 (12) : 2061 - 2068
  • [36] The role of C-type natriuretic peptide in cardiovascular medicine
    Kalra, PR
    Anker, SD
    Struthers, AD
    Coats, AJS
    EUROPEAN HEART JOURNAL, 2001, 22 (12) : 997 - 1007
  • [37] Detection of C-type natriuretic peptide in fetal circulation
    Stepan, H
    Walther, D
    Faber, R
    Walther, T
    JOURNAL OF PERINATAL MEDICINE, 2000, 28 (02) : 118 - 121
  • [38] C-type natriuretic peptide: A new cardiac mediator
    Del Ry, S.
    PEPTIDES, 2013, 40 : 93 - 98
  • [39] The Effects of C-type Natriuretic Peptide on Craniofacial Skeletogenesis
    Nakao, K.
    Okubo, Y.
    Yasoda, A.
    Koyama, N.
    Osawa, K.
    Isobe, Y.
    Kondo, E.
    Fujii, T.
    Miura, M.
    Nakao, K.
    Bessho, K.
    JOURNAL OF DENTAL RESEARCH, 2013, 92 (01) : 58 - 64
  • [40] CARDIOVASCULAR AND RENAL ACTIONS OF C-TYPE NATRIURETIC PEPTIDE
    STINGO, AJ
    CLAVELL, AL
    AARHUS, LL
    BURNETT, JC
    AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (01): : H308 - H312